HRT Financial’s Ionis Pharmaceuticals IONS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$18.9M Buy
252,250
+229,322
+1,000% +$18.1M 0.05% 352
2025
Q4
$1.81M Buy
+22,928
New +$1.73M 0.01% 1373
2025
Q2
Sell
-25,824
Closed -$779K 3082
2025
Q1
$779K Buy
+25,824
New +$846K ﹤0.01% 1244
2024
Q3
Sell
-159,685
Closed -$7.61M 2766
2024
Q2
$7.61M Buy
159,685
+93,182
+140% +$3.82M 0.04% 291
2024
Q1
$2.88M Buy
+66,503
New +$3.17M 0.02% 434
2023
Q4
Sell
-114,600
Closed -$5.2M 2685
2023
Q3
$5.2M Buy
114,600
+109,117
+1,990% +$4.5M 0.05% 280
2023
Q2
$224K Buy
+5,483
New +$211K ﹤0.01% 1785
2022
Q3
Sell
-122,897
Closed -$4.55M 3143
2022
Q2
$4.55M Buy
122,897
+13,521
+12% +$510K 0.05% 278
2022
Q1
$4.05M Buy
+109,376
New +$3.58M 0.03% 349
2021
Q4
Sell
-128,087
Closed -$4.3M 3603
2021
Q3
$4.3M Buy
+128,087
New +$4.83M 0.03% 368
2021
Q1
Sell
-48,427
Closed -$2.74M 2891
2020
Q4
$2.74M Buy
+48,427
New +$2.41M 0.06% 259
2020
Q3
Sell
-21,624
Closed -$1.27M 2112
2020
Q2
$1.27M Buy
+21,624
New +$1.2M 0.04% 469
2019
Q4
Sell
-54,813
Closed -$3.28M 1384
2019
Q3
$3.28M Buy
+54,813
New +$3.57M 0.16% 106

Other funds holding IONS

HRT Financial's IONS Position: Q1 2026 in Review

HRT Financial increased its Ionis Pharmaceuticals (IONS) stake by 1,000% in Q1 2026, buying an estimated $18.1M and bringing the position to 252,250 shares worth $18.9M. The position accounts for 0.05% of the portfolio, ranked #352.

HRT Financial first reported a position in IONS in Q3 2019 and has held it in 13 quarters since. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

  • HRT Financial held 252,250 shares of Ionis Pharmaceuticals worth $18.9M as of Q1 2026.
  • HRT Financial bought 229,322 Ionis Pharmaceuticals shares in Q1 2026, an estimated $18.1M.
  • Ionis Pharmaceuticals made up 0.05% of HRT Financial's portfolio in Q1 2026, its #352 holding.
  • HRT Financial first reported a position in Ionis Pharmaceuticals in Q3 2019 and has held it in 13 quarters since.
  • 493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.